This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Saunders, N. B. Articles by Zollinger, W. D. Search for Related Content PubMed PubMed Citation Articles by Saunders, N. B. Articles by Zollinger, W. D.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, Dec 1997, 3215-3219, Vol 35, No. 12
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Confirmation of suspicious cases of meningococcal meningitis by PCR and enzyme-linked immunosorbent assay [In Process Citation]

NB Saunders, DR Shoemaker, BL Brandt and WD Zollinger
Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, D.C. 20307-5100, USA. Dr._Nancy_Saunders@wrsmtp- ccmail.army.mil

A significant problem in efficacy trials of meningococcal vaccines has been accurate identification of all cases of meningococcal disease that occur in study populations. The accuracy of case determination would be improved by utilizing methods which confirm or disprove suspicious cases of meningococcal disease that are culture negative. A collection of serum and cerebrospinal fluid (CSF) samples from a meningococcal vaccine field trial performed in Iquique, Chile, were utilized to assess the status of patients for whom cultures, Gram stains, and clinical evaluations for meningococcal disease were available. Nested PCRs (nPCRs) for amplification of Neisseria meningitidis DNA in CSF samples and enzyme-linked immunosorbent assays (ELISAs) for quantification of serum immunoglobulin G antibodies specific for N. meningitidis were used in combination to confirm or eliminate cases classified by physicians as suspicious for meningococcal disease. Samples from 12 of 79 patients suspected of having meningococcal meningitis tested positive by both methods; specimens from 61 of the 79 were negative by both methods; and samples from 6 patients yielded ambiguous results, and these cases remained unconfirmed. Direct sequence analysis of amplified DNA from patients suspected of having meningococcal disease confirmed that 2 of the 12 newly confirmed cases were not attributable to the typical epidemic strain (B:15:P1.[7],3) while the others were due to the epidemic strain. A combination of nPCR and ELISA reduced the number of suspicious cases in this study from 79 to 6, thereby improving the potential for assessment of vaccine efficacy. Molecular identification by nPCR in conjunction with immunological assessment of patient response could be considered diagnostic of disease in future testing of meningococcal vaccines to improve efficacy analyses.

This article has been cited by other articles:

• Shoemaker, D. R., Saunders, N. B., Brandt, B. L., Moran, E. E., LaClair, A. D., Zollinger, W. D. (2005). Intranasal Delivery of Group B Meningococcal Native Outer Membrane Vesicle Vaccine Induces Local Mucosal and Serum Bactericidal Antibody Responses in Rabbits. Infect. Immun. 73: 5031-5038 [Abstract] [Full Text]  
• Fisseha, M., Chen, P., Brandt, B., Kijek, T., Moran, E., Zollinger, W. (2005). Characterization of Native Outer Membrane Vesicles from lpxL Mutant Strains of Neisseria meningitidis for Use in Parenteral Vaccination. Infect. Immun. 73: 4070-4080 [Abstract] [Full Text]  
• Bryant, P. A., Li, H. Y., Zaia, A., Griffith, J., Hogg, G., Curtis, N., Carapetis, J. R. (2004). Prospective Study of a Real-Time PCR That Is Highly Sensitive, Specific, and Clinically Useful for Diagnosis of Meningococcal Disease in Children. J. Clin. Microbiol. 42: 2919-2925 [Abstract] [Full Text]  
• Schuurman, T., de Boer, R. F., Kooistra-Smid, A. M. D., van Zwet, A. A. (2004). Prospective Study of Use of PCR Amplification and Sequencing of 16S Ribosomal DNA from Cerebrospinal Fluid for Diagnosis of Bacterial Meningitis in a Clinical Setting. J. Clin. Microbiol. 42: 734-740 [Abstract] [Full Text]  
• Katial, R. K., Brandt, B. L., Moran, E. E., Marks, S., Agnello, V., Zollinger, W. D. (2002). Immunogenicity and Safety Testing of a Group B Intranasal Meningococcal Native Outer Membrane Vesicle Vaccine. Infect. Immun. 70: 702-707 [Abstract] [Full Text]  
• Clarke, S C, Reid, J, Thom, L, Denham, B C, Edwards, G F S (2002). Laboratory confirmation of meningococcal disease in Scotland, 1993-9. J. Clin. Pathol. 55: 32-36 [Abstract] [Full Text]  
• SEWARD, R.J., TOWNER, K.J. (2000). Evaluation of a PCR-immunoassay technique for detection of Neisseria meningitidis in cerebrospinal fluid and peripheral blood. J Med Microbiol 49: 451-456 [Abstract] [Full Text]  
• Wedege, E., Caugant, D. A., Musacchio, A., Saunders, N. B., Zollinger, W. D. (1999). Redesignation of a Purported P1.15 Subtype-Specific Meningococcal Monoclonal Antibody as a P1.19-Specific Reagent. CVI 6: 639-642 [Abstract] [Full Text]  
• Saunders, N. B., Shoemaker, D. R., Brandt, B. L., Moran, E. E., Larsen, T., Zollinger, W. D. (1999). Immunogenicity of Intranasally Administered Meningococcal Native Outer Membrane Vesicles in Mice. Infect. Immun. 67: 113-119 [Abstract] [Full Text]